Procter & Gamble Total Cost of Revenue decreased by 1.0% to $10.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.6%, from $9.69B to $10.72B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 2.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.79B | $10.37B | $10.66B | $10.33B | $10.80B | $10.85B | $10.90B | $10.40B | $10.61B | $10.50B | $10.14B | $9.86B | $10.35B | $10.42B | $10.42B | $9.69B | $10.63B | $10.89B | $10.83B | $10.72B |
| QoQ Change | — | +5.9% | +2.9% | -3.2% | +4.6% | +0.4% | +0.5% | -4.5% | +2.0% | -1.1% | -3.4% | -2.8% | +5.0% | +0.7% | -0.0% | -6.9% | +9.7% | +2.4% | -0.5% | -1.0% |
| YoY Change | — | — | — | — | +10.3% | +4.6% | +2.2% | +0.8% | -1.7% | -3.2% | -6.9% | -5.3% | -2.5% | -0.8% | +2.7% | -1.6% | +2.7% | +4.5% | +4.0% | +10.6% |
| Segment | Q3 '26 |
|---|---|
| Fabric & Home Care | $4.07B |
| Baby, Feminine & Family Care | $2.75B |
| Beauty | $1.58B |
| Health Care | $1.28B |
| Grooming | $642.00M |
| Total | $10.72B |